🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for ITP - Immune Thrombocytopenia

The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) NCT07065968Phase 23 sites📍 Beijing📍 Beijing📍 Beijing Peking University People's Hospital · Tests: Teriflunomide, Dexamethasone CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases NCT06941129Phase 11 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: UCAR T-cell Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia NCT05931718n/a1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: cytokine essays, NGS, Fecal microbiome, Erythropoietin, Luspatercept A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP) NCT07059000Phase 328 sites📍 Los Angeles📍 Shirley📍 Greenville Kedrion S.p.A. · Tests: Kedrion IVIG 10% Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study NCT07133659Phase 41 site📍 Baghdad Al-Mustansiriyah University · Tests: Avatrombopag 20 mg Oral Tablet Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders NCT07104565Phase 239 sites📍 Glendale📍 Los Angeles📍 Lone Tree Incyte Corporation · Tests: INCA000585 Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP) NCT06168851Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Anti-CD38 antibody Injection The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP NCT06479291NA7 sites📍 Shanghai📍 Shanghai📍 Shanghai Yunfeng Cheng · Tests: Hydroxychloroquine Oral Tablet, Eltrombopag Safety Study of CC312 in Autoimmune Disease Patients NCT06888960EARLY Phase 11 site📍 Tianjin CytoCares Inc · Tests: CC312 Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP) NCT07063199Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Daratumumab Injection Management of Children With Persistent ITP, A Novel Approach NCT07068126NA3 sites📍 Asyut📍 Cairo📍 Zagazig Assiut University · Tests: Mini-Pool IVIG A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia NCT06948318Phase 3118 sites📍 Hot Springs📍 Los Angeles📍 San Diego Takeda · Tests: Mezagitamab Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia NCT06817395n/a1 site📍 Boston Massachusetts General Hospital A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP) NCT06094881Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Obinutuzumab Injection [Gazyva] A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia NCT07017725Phase 1, Phase 26 sites📍 Tangshan📍 Zhengzhou📍 Nanchang CASI pharmaceuticals, Inc. · Tests: CID-103 High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia NCT07559331Phase 31 site📍 Jinan Shandong University · Tests: High-Dose Dexamethasone Combined with Orelabrutinib, High-Dose Dexamethasone Combined with Placebo Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune Thrombocytopenia NCT07788456Phase 41 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: standard-dose methylprednisolone/prednisone., thrombopoietin receptor agonist(TPO-RA), including but not limited to het… V-IMMUNE® for Immune Thrombocytopenia NCT06962631Phase 32 sites📍 Recife📍 São Paulo On Pharma Importadora, Exportadora e Distribuidora de Medic… · Tests: 5% (5g/100 ml) intravenous immunoglobin Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia NCT07657793Phase 2, Phase 31 site📍 Beijing Chinese SLE Treatment And Research Group · Tests: Sirolimus, Placebo Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura NCT07093606NA1 site📍 Sohag Sohag University · Tests: Eltrombopag An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases NCT07174843EARLY Phase 11 site📍 Shanghai Shanghai Cell Therapy Group Co.,Ltd · Tests: CD19/CD22/BCMA CAR-T cells(BZE2204) Observatory of Immunological Thrombopenic Purpura in the Brest Region NCT06556888n/a1 site📍 Brest University Hospital, Brest Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease NCT07549698Phase 1, Phase 212 sites📍 Boston📍 Rochester📍 Omaha CRISPR Therapeutics AG · Tests: CTX112 Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) NCT07362238Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Rituximab, Daratumumab Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia NCT04005638n/a1 site📍 Pessac University Hospital, Bordeaux · Tests: blood sample, urine sample The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia NCT05599880Phase 24 sites📍 Guri-si📍 Seoul📍 Seoul Seoul National University Hospital · Tests: Bortezomib Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia. NCT06531018Phase 1, Phase 21 site📍 Dhaka Renata PLC · Tests: Eltrombopag 25 MG, Prednisolone Role of Acute Phase Proteins In Diagnosis of Immune Thrombocytopenia NCT06715215NA1 site📍 Sohag Sohag University · Tests: Acute phase proteins A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia NCT05214391Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Zanubrutinib Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura NCT04323748Phase 11 site📍 Vahalla New York Medical College · Tests: rituxan
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy